Inaugurated by IN-SPACe
ISRO Registered Space Tutor
S7-SA6-0651
What is Balancing Innovation and Access to Medicines?
Grade Level:
Class 12
AI/ML, Physics, Biotechnology, FinTech, EVs, Space Technology, Climate Science, Blockchain, Medicine, Engineering, Law, Economics
Definition
What is it?
Balancing innovation and access to medicines means finding a way to encourage companies to create new, life-saving drugs while also making sure these medicines are affordable and available to everyone who needs them, especially in countries like India. It's about ensuring both progress in medical science and fairness in healthcare.
Simple Example
Quick Example
Imagine a new, super effective medicine for fever that works instantly. If the company sells it for ₹5000 per tablet, only rich people can buy it. Balancing means finding a price, say ₹50, that covers the company's research cost but also allows most families, like yours, to afford it when someone is sick.
Worked Example
Step-by-Step
Let's say a company spends ₹1000 Crores (10 billion rupees) to develop a new cancer drug.
---1. They estimate 10 lakh (1 million) patients in India need this drug.
---2. If they price it at ₹50,000 per dose, they will earn ₹5000 Crores (50 billion rupees), making a huge profit but making it unaffordable for most.
---3. If they price it at ₹5000 per dose, they will earn ₹500 Crores, losing money and discouraging future research.
---4. A government or international body might step in and offer to buy the drug in bulk at ₹15,000 per dose, covering the company's costs and allowing them to sell it to patients for ₹2000 per dose through subsidies.
---5. This way, the company recovers its investment and can innovate further, while many more patients can access the medicine.
---Answer: A balanced price and access model ensures both innovation and affordability.
Why It Matters
This balance is crucial for public health and economic fairness. It drives breakthroughs in Biotechnology and Medicine, helping us fight diseases like cancer and diabetes. People working in Law, Economics, and public policy often deal with these complex issues to ensure a healthier future for everyone.
Common Mistakes
MISTAKE: Thinking that companies should give medicines for free since they are life-saving. | CORRECTION: Companies spend a lot on research (like building a new EV or space rocket) and need to recover costs to keep innovating. The goal is fair pricing, not free.
MISTAKE: Believing that only rich countries face this problem. | CORRECTION: Developing countries like India face this challenge even more acutely, as a large population needs affordable access to essential medicines.
MISTAKE: Assuming that innovation only means new drugs. | CORRECTION: Innovation also includes making existing drugs better, more effective, or easier to produce and distribute, which can also improve access.
Practice Questions
Try It Yourself
QUESTION: Why might a pharmaceutical company charge a high price for a new, life-saving medicine? | ANSWER: To recover the huge costs of research, development, and testing, and to fund future innovations.
QUESTION: Name two ways governments can help improve access to expensive medicines for their citizens. | ANSWER: Governments can offer subsidies (financial help), negotiate bulk purchase discounts, or encourage generic drug production.
QUESTION: A new vaccine costs ₹2000 per dose to produce. If a company wants to make a 20% profit and needs to sell 10 lakh doses to cover its development costs, what would be the total development cost? | ANSWER: Selling price per dose = ₹2000 + (20% of ₹2000) = ₹2000 + ₹400 = ₹2400. Total revenue needed from 10 lakh doses = ₹2400 * 10,00,000 = ₹240 Crores. So, the total development cost would be ₹240 Crores minus the 20% profit margin from that revenue, which is ₹200 Crores (₹240 Crores / 1.20).
MCQ
Quick Quiz
What is the main challenge in balancing innovation and access to medicines?
Companies don't want to innovate new medicines.
Making medicines affordable often means less money for future research.
People don't want to take new medicines.
There are too many medicines already available.
The Correct Answer Is:
B
The core challenge is that lowering prices to improve access reduces a company's profit, which then limits their ability or incentive to invest in expensive new research and development for future innovations. Options A, C, and D are generally not the primary challenges.
Real World Connection
In the Real World
In India, the Jan Aushadhi Kendras (People's Medicine Centres) are a great example. They sell quality generic medicines at much lower prices than branded ones, making essential drugs accessible to millions. This initiative helps balance access by providing affordable alternatives while still allowing branded companies to innovate.
Key Vocabulary
Key Terms
INNOVATION: Creating new and better ways of doing things, like developing a new medicine. | ACCESS: The ability for people to get and afford something, like medicines. | GENERIC MEDICINE: A copy of a branded medicine that has the same active ingredients but is sold at a much lower price after the patent expires. | SUBSIDY: Financial help given by a government or organization to make something more affordable. | PHARMACEUTICAL COMPANY: A company that researches, develops, manufactures, and distributes medicines.
What's Next
What to Learn Next
Next, you can explore 'Intellectual Property Rights and Patents.' Understanding patents will show you how companies protect their innovations and how that impacts the pricing and availability of medicines, building directly on what you learned here.
